LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: New therapeutic agents for diabetes mellitus: implications for anesthetic management.

Chen, Daniel / Lee, Stephanie L / Peterfreund, Robert A

Anesthesia and analgesia

2009  Volume 108, Issue 6, Page(s) 1803–1810

Abstract: ... Anesthesia providers caring for patients with diabetes mellitus will need to understand the implications ... for new treatments for diabetes mellitus. Therapies based on glucagon-like peptide 1 and amylin have now ... for this indication. This drug exhibited therapeutic benefits for metabolic variables and for type 2 diabetes mellitus ...

Abstract Multiple hormones and transmitter systems contribute to glucose homeostasis and the control of metabolism. Recently, the gastrointestinal peptide hormones glucagon-like peptide 1 and amylin have been shown to significantly contribute to this complex physiology. These advances provide the foundation for new treatments for diabetes mellitus. Therapies based on glucagon-like peptide 1 and amylin have now been introduced into clinical practice. Rimonabant, the selective endocannabinoid receptor antagonist, had been used in European countries for the treatment of obesity; it has recently been withdrawn for this indication. This drug exhibited therapeutic benefits for metabolic variables and for type 2 diabetes mellitus. Anesthesia providers caring for patients with diabetes mellitus will need to understand the implications of these new therapies in perioperative settings, particularly with respect to side effects and interactions.
MeSH term(s) Amyloid/therapeutic use ; Anesthesia ; Animals ; Cannabinoid Receptor Modulators/physiology ; Diabetes Mellitus/drug therapy ; Glucagon-Like Peptide 1/therapeutic use ; Humans ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Incretins/physiology ; Islet Amyloid Polypeptide
Chemical Substances Amyloid ; Cannabinoid Receptor Modulators ; Hypoglycemic Agents ; Incretins ; Islet Amyloid Polypeptide ; Glucagon-Like Peptide 1 (89750-14-1)
Language English
Publishing date 2009-06
Publishing country United States
Document type Journal Article ; Review
ZDB-ID 80032-6
ISSN 1526-7598 ; 0003-2999
ISSN (online) 1526-7598
ISSN 0003-2999
DOI 10.1213/ane.0b013e31819dcc51
Shelf mark
Uk I Zs.78: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Zs.MO 149: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top